Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: Case reports and review of the literature

AIDS Research and Human Retroviruses

Volumn 21, Issue 9, 2005, Pages 753-756

  Dillmon, Melissa S ^a   Saag, Michael S ^a   Hamza, Sate H ^b   Adler, Brian K ^a   Marques, Marisa B ^b,c  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOW MOLECULAR WEIGHT HEPARIN; NELFINAVIR; PROTEIN S; RITONAVIR; SAQUINAVIR; TENOFOVIR; WARFARIN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTICOAGULATION; BUDD CHIARI SYNDROME; CASE REPORT; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HORMONAL THERAPY; HUMAN; IMMOBILIZATION; LEG ULCER; MALE; MICROTHROMBUS; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; REVIEW; SKIN BIOPSY; THROMBOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CHRONIC DISEASE; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; MALE; MIDDLE AGED; PROTEIN S DEFICIENCY; REVIEW LITERATURE; SKIN ULCER; THROMBOSIS;

EID: 26444578410     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.753     Document Type: Review

References (29)

1. Pabinger I, Brucker S, Kyrie PA, et al.: Hereditary deficiency of antithrombin III, protein C and protein S: Prevalence in patients with a history of venous thrombosis and criteria for national patient screening. Blood Coagul Fibrinolysis 1992;3:547-553.
2. Gladson CL, Scharer I, Hach V, Beck KH, and Griffin JH: The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost 1988;59:18-22.
3. Comp PC and Esmon C: Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984;311:1525-1528.
4. Saif MW and Greenberg B: HIV and thrombosis: A review. AIDS Patient Care 2001;15:15-24.
5. Saber AA, Aboolian A, LaRaja RD, Baron H, and Hanna K: HIV/AIDS and the risk of deep vein thrombosis: A study of 45 patients with lower extremity involvement. Am Surg 2001; 67:645-647.
6. Copur AS, Smith PR, Gomez V, Bergman M, and Homel P: HIV infection is a risk factor for venous thromboembolism. AIDS Patient Care STDS 2002;16:205-209.
7. Qureshi AI, Janssen RS, Karon JM, et al.: Human immunodeficiency virus infection and stroke in young patients. Arch Neurol 1997;54:1150-1153.
8. Mochan A, Modi M, and Modi G: Stroke in black South African HIV-positive patients. Stroke 2003;34:10-15.
9. Sullivan PS, Dworkin MS, Jones JL, and Hooper WC: Epidemiology of thrombosis in HIV-infected individuals. AIDS 2000; 14:321-324.
10. LaFeuillade A, Alessi MC, Poizot-Martin I, et al.: Protein S deficiency and HIV infection. N Engl J Med 1991;324:1220.
11. LaFeuillade A, Alessi MC, Poizot-Martin I, et al.: Endothelial cell dysfunction in HIV infection. J Acquir Immune Defic Syndr 1992;5:127-131.
12. Bissuel F, Berruyer M, Causse X, Deechavanne M, and Trepo C: Acquired protein S deficiency: Correlation with advanced disease in HIV-1 infected patients. J Acquir Immune Defic Syndr 1992;5:484-489.
13. Stahl C, Wideman C, Spira T, Haff E, Hixon G, and Evatt B: Protein S deficiency in men with long-term human immunodeficiency virus infection. Blood 1993;81:1801-1807.
14. Sugerman R, Church J, Goldsmith J, and Ens G: Acquired protein S deficiency in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1996;15:106-111.
15. Banerjee D, Grey J, and Harding KG: An unusual cause of leg ulceration. Postgrad Med J 1999;75:247-248.
16. Tsutsui K, Ishida W, Ohashi T, and Takehara K: Hereditary type IIb protein S deficiency in a patient with recurrent venous ulcers. Dermatology 1997;194(2):198-199.
17. Kulthanan K, Krudum T, Pintadit P, Khokkaseam R, and Kullavanijaya P: Chronic leg ulcers associated with hereditary protein S deficiency. Int J Dermatol 1997;36:210-212.
18. Vicente V, Alberca I, Tabernero MD, and Lopez Borrasca AL: Ulcer necrotic legs as first manifestation of protein S deficiency. Blut 1987;54:253-254.
19. Janssen H, Meinardi J, Vleggaar F, et al.: Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Result of a case-control study. Blood 2000;96: 2364-2368.
20. Mohanty D, Shetty S, Ghosh K, Pawar A, and Abraham P: Hereditary thrombophilia as a cause of Budd-Chiari syndrome: A study from western India. Hepatology 2001;34:666-670.
21. De BK, De KK, Sen S, et al.: Etiology based prevalence of Budd-Chiari Syndrome in eastern India. J Assoc Physicians India 2000;48:800-803.
22. Hooper WC, Phillips DJ, Ribeiro M, et al.: Tumor necrosis factor-α downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the HEpG-2 hepatoma cell line. Blood 1994;84(2):483-489.
23. de Larranaga GF, Forastiero RR, Carreras LO, et al.: Different types of antiphospholipid antibodies in AIDS: A comparison with syphilis and the antiphospholipid syndrome. Thromb Res 1999;96:19-25.
24. Abuaf N, Laperche S, Rajoely B, et al.: Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 1997;77(5):856-861.
25. LaFeuillade A, Sorice M, Griggi T, Pellegrino P, Geoffroy M, and Profizi N: Role of autoimmunity in protein S deficiency during HIV-1 infection. Infection 1994;22(3):201-203.
26. Eastone JA and Decker CF: New onset diabetes mellitus associated with the use of protease inhibitors. Ann Intern Med 1997;127(10):948.
27. Monier P, McKown K, and Bronze M: Osteonecrosis complicating highly active anti-retroviral therapy in patients infected with HIV. Clin Infect Dis 2000;31(6):1488-1492.
28. Tebas P, Powderly WG, Claxton S, et al.: Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 2000;14(4):F63-F67.
29. Carr A, Samaras K, Burton S, et al.: A syndrome of peripheral lipodystrophy, hyperlipidemia, and insulin-resistance in patients receiving HIV-1 protease inhibitors. AIDS 1998;12:F51-F58.